| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.2M | -24.2% |
| R&D Expense | $29K | -97.8% |
| SG&A Expense | $12.8M | -33.1% |
| Operating Income | -$22.1M | +21.1% |
| Pre-tax Income | -$23.3M | +19.8% |
| Income Tax | -$1.2M | -310.1% |
| Net Income | -$22.1M | +23.2% |
| EPS (Basic) | -$1.92 | +53.6% |
| EPS (Diluted) | -$1.92 | +53.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $764K | -33.4% |
| Accounts Receivable | $837K | -25.6% |
| Current Assets | $11.9M | -30.4% |
| Total Assets | $12.9M | -59.3% |
| Current Liabilities | $19.0M | -8.9% |
| Long-term Debt | $17.8M | -8.3% |
| Total Liabilities | $40.6M | -10.0% |
| Stockholders' Equity |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.2M | +3.8% |
| Investing Cash Flow | $227K | -77.9% |
| Financing Cash Flow | $10.7M | +109.4% |
| -$27.7M |
| -106.2% |